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Alkaline Earth catalysis for the 100% Atom-Efficient 
Three Component Assembly of Imidazolidin-2-ones 
Merle Arrowsmith, William M. S. Shepherd, Michael S. Hill* and Gabriele Kociok-
Köhn 
 
 
 
 
A variety of functionalised imidazolidin-2-ones may be 
synthesised under very mild reaction conditions using non-
toxic and cost-effective alkaline earth bis(amide) pre-
catalysts in a 100% atom-efficient, intermolecular one-pot 
assembly from inexpensive alkyne and cumulene reagents. 
Heterocyclic molecules play a crucial role in biological processes1 
and are a constituent in two-thirds of the top-selling small molecule 
pharmaceuticals in the USA.2 Azole derivatives are a particularly 
widespread motif in natural products and are among the 30 most 
frequently-used heterocycles in anticancer, anti-HIV and 
antibacterial drug molecules.3,4 Whilst many complex and 
challenging heterocyclic syntheses may be achieved with catalytic 
methods,5 a vast majority of these processes require either the 
preparation of specialised substrates and pre-catalysts derived from 
low abundance transition metals or are atom-inefficient from 
production of halide by-products.6 Since our initial report of the 
calcium-catalysed intramolecular hydroamination of aminoalkenes 
(Scheme 1A),7 we and others have applied pre-catalysts derived 
from the biologically compatible, inexpensive and environmentally 
benign alkaline earth (Ae) elements to an ever-growing array of 
multiple bond heterofunctionalisation and dehydrocoupling 
reactions.8 Of direct relevance to the current work are the group 2 
catalysed hydroacetylenation of carbodiimides (Scheme 1B)9 and the 
recently reported magnesium-mediated but stoichiometric synthesis 
of complex bis(hydantoins) (I, inset Scheme 1) from 
phenylacetylene and isocyanates.10 This latter process was 
rationalised as a cascade of hydroacetylenation, isocyanate insertion, 
intramolecular hydroamination and protonolysis steps akin to those 
depicted in Scheme 1. In this contribution we demonstrate that the 
readily available homoleptic amides, [Ae{N(SiMe3)2}2(THF)2] (1a, 
Ae = Mg; 1b, Ae = Ca; 1c, Ae = Sr), may be employed for the ready 
elaboration of this chemistry to a generalised one pot catalytic 
regime. This is achieved through an initial and precedented catalytic 
reaction of a carbodiimide and terminal acetylene to provide a 
propargylamidine (II, Scheme 1B).9 We speculated that, upon 
completion of this catalysis, addition of an isocyanate would 
instigate the formation of imidazolidin-2-ones (IV) through further 
insertion and protolytic reactivity (Scheme 1C). 
 
 
 
An initial reaction of tert-butylisocyanate with (N,N'-di-
isopropyl)phenylpropargylamidine, synthesised in situ using 5 mol% 
[Sr{N(SiMe3)2}2(THF)2], 1c, resulted in quantitative formation of 
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the imidazolidin-2-one (2) within the first point of analysis at rt 
(Scheme 2, Table 1, entry 3). Analysis by 1H NMR spectroscopy 
revealed a 22:78 mixture of the Z and E isomers displaying 
characteristic benzylidene singlet resonances at 6.50 and 5.95 ppm, 
respectively. Lowering the catalyst loading to 0.5 mol% afforded the 
same isomer mixture in 87% yield after 18h at rt (Table 1, entry 4). 
Performance of an identical reaction with 5 mol% of the analogous 
magnesium and calcium pre-catalysts, 1a and 1b, revealed the 
intermediacy of a highly moisture-sensitive urea derivative (Scheme 
2), identified by comparison with isolated compounds synthesised by 
direct reaction between the isocyanate and the amidine (see 
Supporting Information). 
 
 
 
Subsequent reactions were performed at rt with 0.5 mol% 1c, 
using (N,N'-di-isopropyl)phenylpropargylamidine and the range of 
isocyanates shown in Table 1. In all cases isocyanate insertion was 
virtually instantaneous at rt whereas the rate of cyclisation to the 
corresponding imidazolidin-2-one was found to be dependent on the 
steric pressure exerted by the isocyanate substituent: ethylisocyanate 
afforded a 91% NMR yield within 20 min at rt (Table 1, entry 5), 
while the larger, tert-butyl-, adamantyl and 2,6-di-iso-propylphenyl-
isocyanates, required 18 hours to achieve good conversions (Table 1, 
entries 4, 9 and 12). 
 
Ent. R, Compd. No. 
cat 
(mol%) 
Time 
(h) 
NMR 
yield 
(%) 
Z/E 
(%) 
1 tBu, 2 1a 5.0 4d 53 33:67 
2 '' 1b 5.0 2 87 30:70 
3 '' 1c 5.0 0.1 >99 22:78 
4 '' 1c 0.5 18 87 23:77 
5 Et, 3 1c 0.5 0.3 91 83:17 
6 Pr, 4 1c 0.5 0.5 97 90:10 
7 iPr, 5 1c 0.5 3 98 41:59 
8 Cy, 6 1c 0.5 3 >99 40:60 
9 Adamantyl, 7 1c 0.5 18 92 32:68 
10 Ph, 8 1c 0.5 0.5 >99 85:15 
11 2,4,6-Me3Ph, 9 1c 0.5 6 98 98:2 
12 2,6-iPr2C6Ph, 10 1c 0.5 18 78 90:10 
 
With 5 mol% 1c, all reactions proceeded to completion within less 
than 5 min at rt. The Z/E product isomer ratio was found to be 
governed both by steric and electronic factors. Arylisocyanates 
predominantly yielded the Z isomer, independent of substituent 
steric demands (Table 1, entries 10-12). For alkylisocyanates, 
however, selectivity was observed to shift from predominantly Z for 
substituents of lower steric demands (Table 1, entries 5, 6) to 
predominantly E for those exerting greater steric pressure (Table 1, 
entries 1-4, 7-9). To evaluate the scope of amidine N-substitution a 
variety of phenylpropargylamidines were synthesised in situ from 
phenylacetylene and commercially available carbodiimides using 1c 
as a pre-catalyst. Upon full conversion to the amidine 1 eq. 
isopropylisocyanate was added. Formation of the heterocyclic 
products proved highly dependent on the steric demands of the 
amidine N-substituents (Scheme 3). While the di(isopropyl) and 
dicyclohexyl derivatives provided essentially instantaneous and 
quantitative conversion at rt using 5 mol% catalyst (Table 2, entries 
1-2), the larger di(tert-butyl) derivative required much longer 
reaction times (40h) to achieve high conversion (Table 2, entry 3). 
The unsymmetrical 1-ethyl-3-(tert-butyl)amidine substrate provided 
evidence for kinetic discrimination in these reactions through 
exclusive isocyanate insertion at the N-ethyl nitrogen atom, with a 
product isomer ratio intermediate between that of the di(isopropyl) 
and di(tert-butyl) derivatives (entry 4). Substrates with smaller 
functionalities, such as di(p-tolyl)carbodiimide and [1-(N,N'-
dimethylaminopropyl)-3-tert-butyl)carbodiimide did not provide 
access to the desired propargylamidines but underwent double 
carbodiimide insertion/cyclization to yield N,N'-[(5-benzylidene-
imidazolidin-2,4-ylidene)diamine products (Scheme 3, Table 2, 
entries 5,6). In the case of the tetra(p-tolyl)-substituted N-heterocycle 
(14), a 75% selectivity for the Z-isomer was observed (entry 5), in 
line with observations for products derived from arylisocyanates 
(Table 1, entries 10-12). Analysis of the product distribution from 
the reaction of the 1-(N,N'-dimethylaminopropyl)-3-tert-butyl 
derivative was marred by the presence in solution of all 4 possible 
insertion regioisomers as well as E/Z-isomerism (Table 2, entry 6). 
 
In contrast, the strontium-catalysed reaction of isocyanates with 
(N,N'-di-isopropyl)-n-butylpropargylamidine did not afford the 
desired imidazolidin-2-ones but only the urea insertion products (16, 
17) (Scheme 4). The latter species did not undergo cyclisation even 
after prolonged heating at 100 oC. Similarly, group 2-mediated 
intramolecular hydroamination of aminoalkenes has been observed 
to be hindered by the presence of terminal alkyl substituents on the 
alkene moiety, whereas terminal aryl substitution promotes 
cyclisation due to an activating electronic effect.11 
 
Table 2. Propargylamidine scope for the synthesis of 1-isopropyl-
(5-benzylidene-4-imino)imidazolidin-2-ones.  
Ent. R 
R', Compd. 
No. 
cat 
(mol%) 
Time 
(h) 
NMR 
yield 
(%) 
Z/E 
(%) 
1 iPr iPr, 5 5.0 0.1 98 41:59 
2 Cy Cy, 11 5.0 0.1 97 25:75 
3 tBu tBu, 12 5.0 40 75 25:75 
4 Et tBu, 13 5.0 0.1 99 34:66 
5 p-tol p-tol, 14 5.0 4a 97 75:25 
6 Et 
(CH2)3NMe2, 
15 
5.0 4a 89 - b 
(a) 2 eq. RN=C=NR', 80 oC; b) mixture of all 4 regioisomers. 
 
Single crystal X-ray diffraction experiments performed on  the 
products resulting from the reactions of (N,N'-di-isopropyl)-
phenylpropargylamidine with 2,6-di-isopropyl-phenyl- and tert-
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butylisocyanate, respectively, revealed the structures of compounds 
(Z)-10 and (E)-2, which corresponded to the major isomers formed 
in the reactions as observed by solution NMR analysis (Figure 1). In 
both cases bond lengths and angles are within the range expected for 
these (5-benzylidene-4-imino)-imidazolidin-2-ones. 
Figure 1. ORTEP representations of compounds (Z)-10 (left) and (E)-2 
(right) Ellipsoids at 30% probability. Hydrogen atoms omitted for clarity 
except H4. 
 
To investigate the nature of the alkaline earth species at work in 
this catalysis, a stoichiometric reaction between 1a, 2 eq. (N,N'-di-
isopropyl)phenypropargylamidine and 2 eq. 2,6-di-isopropyl-
phenylisocyanate was performed. This did not yield the expected 
magnesium insertion complex but was observed by NMR analysis to 
provide complete conversion of substrates to the corresponding N-
heterocyclic product 10 with reformation of 1a. This result suggests 
that cyclisation is assisted by the presence of protic [HN(SiMe3)2] 
liberated upon amidine protonolysis of 1a. A similar concerted 
mechanism has previously been proposed for the intramolecular 
cyclisation of aminoalkenes (Scheme 1A).11,12 
 
Use of [Mg(CH2Ph)2(THF)2] in place of 1a yielded the desired 
homoleptic insertion complex, compound 18, in quantitative yield 
(Scheme 5). An X-ray diffraction experiment revealed 18 to be a 
distorted square pyramidal bis(N-(2-phenylpropargylimidoyl)-
carbamimidate) magnesium complex, with a THF molecule in the 
axial position. Coordination in the basal plane is provided by the 
oxygen atoms of the inserted isocyanates and the imino-nitrogen of 
the amidinate moieties, forming two 6-membered [MgNCNCO] 
metallacycles (Figure 2). The rather short C-O bond lengths 
[1.275(4), 1.274(4) Å], elongated C1-N1 [1.451(4) Å] and C29-N4 
bonds [1.452(4) Å] and the planarity of the N1 and N4 nitrogen 
atoms suggest some degree of delocalisation over the chelate rings. 
The short C1-N3 [1.289(4) Å] and C29-N6 [1.291(4) Å] bond 
lengths are clearly indicative of pendant imine functionalities. 
 
Figure 2. ORTEP representation of compound 18. Ellipsoids at 30% 
probability. Hydrogen atoms omitted for clarity. 
Complex 18 provided similar catalytic activity to 1a for the 
formation of 2, suggesting that molecules of this type are formed as 
intermediates during the catalysis. Variable temperature 1H NMR 
experiments performed on compound 18 also indicated the potential 
for isocyanate de-insertion at higher temperatures. A van’t Hoff 
analysis of this equilibrium provided H = +88 kJ.mol-1 and S 
=208 J.K-1.mol-1 allowing G◦(298 K) to be estimated as +26 
kJ.mol-1 for the dissociative process. Interpretation of this latter 
value remains difficult as it requires deconvolution of both the de-
insertion and the potential for dimerization of the resultant 
propargylamidinate species.9a The positive but low free energy 
change at 298 K, however, indicates that this potential reversibility is 
likely to be significant during the course of the catalysis at ambient 
or slightly elevated temperatures. This observation and the notable 
regioselectivity of the catalysis toward imidazolidine formation, 
thus, lead us to suggest the refined mechanistic hypothesis depicted 
in Scheme 6. 
Conclusions 
In conclusion we have demonstrated the applicability of readily 
available and inexpensive alkaline earth bis(amide) 
precatalaysts to the facile one-pot, 100% atom-efficient, 
stepwise synthesis of a wide variety of highly functionalized 
imidazolidin-2-ones from simple commercially available 
building blocks. We are currently seeking to develop extensions 
to this catalytic heterocycle synthesis through the incorporation 
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of alternative heterocumulenes into catalytic manifolds 
analogous to those shown in Schemes 1B/C and 6 and to 
exploit the additional functionality inherent in molecules such 
as (Z)-10 and (E)-2 in subsequent, sequential atom-efficient 
transformations. 
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